Previous 10 | Next 10 |
Using cash on hand, Lannett Company (LCI) has fully repaid the remaining outstanding balance of $42M in its Term A Loans.CEO Tim Crew says, "Paying off our Term A Loans is an important achievement and a key step toward strengthening our balance sheet and improving our long-term financial heal...
Lannett Pays Off, In Full, Remaining Term A Loans PR Newswire PHILADELPHIA, Nov. 30, 2020 PHILADELPHIA , Nov. 30, 2020 /PRNewswire/ -- Lannett Company, Inc. (NYSE: LCI) today announced that the company used a portion of its existing cash on hand to pay o...
Gainers: Oncternal Therapeutics (ONCT) +131%, Aptevo Therapeutics (APVO) +42%, Aurora Cannabis (ACB) +36%, Tilray (TLRY) +29%, Akerna (KERN) +26%.Losers: Clovis Oncology (CLVS) -21%, bluebird bio (BLUE) -17%, Lannett Compan...
Image source: The Motley Fool. Lannett Inc (NYSE: LCI) Q1 2021 Earnings Call Nov 4, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Lannett Inc (LCI) Q1 2021 Earnings Call Transcript
Lannett Company, Inc. (LCI) Q1 2021 Results Conference Call November 04, 2020 04:30 PM ET Company Participants Robert Jaffe - IR Tim Crew - CEO John Kozlowski - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Gary Nachman - BMO Capital Markets Scott Henry - Roth Capi...
Lannett (LCI): FQ1 Non-GAAP EPS of $0.06 misses by $0.04; GAAP EPS of -$0.17 misses by $0.20.Revenue of $126.48M (-0.7% Y/Y) misses by $2.46M.Press Release For further details see: Lannett EPS misses by $0.04, misses on revenue
Lannett Announces Fiscal 2021 First-quarter Financial Results; Affirms Guidance Financial and Business Highlights: - Q1 Net Sales of $126 Million - Q1 Adjusted EBITDA of $33 Million - Commenced Marketing Four Products in FY21 Q1 - Fully Implemented $15 Million of...
Lannett (NYSE:LCI) is scheduled to announce FQ1 earnings results on Wednesday, November 4th, after market close.The consensus EPS Estimate is $0.10 (-54.5% Y/Y) and the consensus Revenue Estimate is $128.94M (+1.3% Y/Y).Over the last 2 years, LCI has beaten EPS estimates 75% of the time and h...
Lannett (LCI) launched the authorized generic of Tirosint (Levothyroxine Sodium Capsules USP) and inked an exclusive U.S. distribution agreement with Switzerland-based IBSA Institut Biochimique, a global pharmaceutical company.Under the agreement, Lannett will primarily provide sale...
Lannett Launches Authorized Generic of Tirosint® (Levothyroxine Sodium Capsules) --Unique Oral Formulation of Levothyroxine Expands Thyroid Deficiency Product Portfolio-- PR Newswire PHILADELPHIA, Nov. 3, 2020 PHILADELPHIA , Nov. 3, 2020 /PRNewsw...
News, Short Squeeze, Breakout and More Instantly...
Lannett Co Inc Company Name:
LCI Stock Symbol:
NYSE Market:
NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGS PR Newswire Company Expects No Impact on Operations Negotiations with Key Secured Creditors Progressing Toward a Balance Sheet Strengthening Transaction ...
LANNETT SHARES UPDATE PR Newswire Announces Positive Results from Pivotal Clinical Insulin Trial that Demonstrates Biosimilarity to Reference Product Productive Conversations with Key Secured Creditors Toward a Balance Sheet Strengthening, Recapitalization or Res...